The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
The vascular endothelial growth factor as a predictive and prognostic factor in patients with advanced gastric cancer treated with docetaxel, cisplatin, and 5-florouracil (DCF) regimen.
Sedef H. Aktas
No relevant relationships to disclose
Hakan Akbulut
No relevant relationships to disclose
Ozan Yazici
No relevant relationships to disclose
Nurullah Zengin
No relevant relationships to disclose
Nalan Akgun
No relevant relationships to disclose
Zeki Ustuner
No relevant relationships to disclose
Fikri Icli
No relevant relationships to disclose